Morgan Stanley’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Morgan Stanley’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,415	Closed	-$267K	–	8001
2022 Q4	$267K	Sell	7,415 -2,556	-26%	-$63.9K	﹤0.01%	5551
2022 Q3	$150K	Sell	9,971 -611	-6%	-$9.9K	﹤0.01%	5877
2022 Q2	$142K	Sell	10,582 -5,532	-34%	-$87.8K	﹤0.01%	6080
2022 Q1	$311K	Buy	16,114 +7,399	+85%	+$154K	﹤0.01%	5671
2021 Q4	$207K	Buy	8,715 +6,218	+249%	+$144K	﹤0.01%	6048
2021 Q3	$50K	Buy	+2,497	New	+$53.6K	﹤0.01%	6732

Morgan Stanley's IMGO Position: Q1 2023 in Review

Morgan Stanley sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 7,415 shares — an estimated $267K sold.

Morgan Stanley first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $311K in Q1 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Morgan Stanley reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Morgan Stanley sold 7,415 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $267K.
Morgan Stanley first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Morgan Stanley's Imago BioSciences, Inc. Common stock position peaked at $311K in Q1 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.